Patents
Patents for C07K 19 - Hybrid peptides (29,428)
02/2002
02/28/2002CA2420257A1 Identification of a cam-kinase ii inhibitor
02/28/2002CA2420087A1 Cripto tumour polypeptide
02/28/2002CA2419872A1 Identification of a human n-terminal acetyltransferase gene
02/28/2002CA2419810A1 Mfq-111, a novel human gtpase like protein
02/28/2002CA2419029A1 Bacillus thuringiensis crystal protein hybrids
02/28/2002CA2356124A1 Anti-ige vaccines
02/27/2002EP1182213A1 Hybrid enzyme and use thereof
02/27/2002EP1181549A1 Protein-protein interactions
02/27/2002EP1181378A1 Fusion proteins comprising a fragment of a chaperon polypeptide
02/27/2002EP1181369A1 Four-helical bundle protein zsig81
02/27/2002EP1181366A1 Mammalian receptor proteins; related reagents and methods
02/27/2002EP1181317A1 An integrin heterodimer and an alpha subunit thereof
02/27/2002CN1337403A Active monopeptide prepared from active blood polypeptide and its prepn. activity and sequence
02/26/2002CA2083177C Alveolar surfactant proteins
02/26/2002CA2038030C Synthetic peptides which contain sequences from factor viia, and the use thereof
02/21/2002WO2002014489A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
02/21/2002WO2002014478A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
02/21/2002WO2002014370A1 Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
02/21/2002WO2002014369A2 Human kininogen d5 domain polypeptides and their use
02/21/2002WO2002014355A2 Novel mitogen activated kinase
02/21/2002WO2002014351A2 α7 NICOTINIC RECEPTOR PEPTIDES AS LIGANDS FOR β AMYLOID P EPTIDES
02/21/2002WO2002013862A2 Method and composition for altering a b cell mediated pathology
02/21/2002WO2002013763A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
02/21/2002WO2001079443A3 Albumin fusion proteins
02/21/2002WO2001077149A3 Regulation of human cyslt2-like gpcr protein
02/21/2002WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
02/21/2002WO2001049832A3 Transduction of recombinases for inducible gene targeting
02/21/2002WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use
02/21/2002WO2001043695A3 Peptide constructs for treating autoimmune and related diseases
02/21/2002WO2001032871A3 Follistatin-related protein zfsta4
02/21/2002US20020022025 Anticoagulants
02/21/2002DE10038382A1 Zweifarbiges fluorimetrisches Proteaseassay Two-toned fluorometric protease assay
02/21/2002CA2420037A1 Immunogenic hbc chimer particles having enhanced stability
02/21/2002CA2419545A1 .alpha.7 nicotinic receptor peptides as ligands for .beta. amyloid peptides
02/21/2002CA2419491A1 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
02/21/2002CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
02/21/2002CA2418266A1 Novel mitogen activated kinase
02/21/2002CA2416898A1 Method and composition for altering a b cell mediated pathology
02/20/2002EP1180168A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
02/20/2002EP1180147A1 Secreted alpha-helical protein-31
02/20/2002EP1180122A1 Structural models for cytoplasmic domains of transmembrane receptors
02/20/2002EP1180121A1 Long lasting insulinotropic peptides
02/19/2002US6348568 Hybrid polypeptides with enhanced pharmacokinetic properties
02/19/2002US6348334 DNA encoding Fas ligand
02/14/2002WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
02/14/2002WO2002012345A2 Soluble zcytor 11 cytokine receptors
02/14/2002WO2002012339A2 Sequences for integrin alpha-8
02/14/2002WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
02/14/2002WO2002012286A2 Stress proteins and peptides and methods of use thereof
02/14/2002WO2002012281A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
02/14/2002WO2002012274A2 Iapl-3 a protein inhibitor of apoptosis proteins
02/14/2002WO2002005844A8 Protein complex serving as a vehicle for orally administerable medicaments
02/14/2002WO2001081415A9 Parathyroid hormone and parathyroid hormone-related protein antagonists
02/14/2002WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation)
02/14/2002WO2001059120A3 Il-17 like molecules and uses thereof
02/14/2002WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels
02/14/2002WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10
02/14/2002WO2001057183A3 Method for producing circular or multimeric protein species in vivo or in vitro and related methods
02/14/2002WO2000073337A9 Polymer conjugates of hedgehog proteins and uses
02/14/2002WO2000044908A9 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
02/14/2002US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis
02/14/2002US20020019350 Targeted angiogenesis
02/14/2002CA2418950A1 Soluble zcytor 11 cytokine receptors
02/14/2002CA2418834A1 Iapl-3 a protein inhibitor of apoptosis proteins
02/14/2002CA2418445A1 Stress proteins and peptides and methods of use thereof
02/14/2002CA2417707A1 Sid.rtm. nucleic acids and polypeptides selected from a pathogenic strain of hepatitis c virus and applications thereof
02/14/2002CA2417676A1 Sequences for integrin alpha-8
02/14/2002CA2417214A1 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
02/14/2002CA2416982A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
02/13/2002EP1179593A1 Process for producing recombinant insulin from novel fused protein
02/13/2002EP1179015A1 Dna molecules encoding human clax proteins and their soluble fusion proteins
02/13/2002EP1179007A1 Self-assembling biomolecular structures
02/13/2002EP1178828A1 Death domain containing receptor 4
02/13/2002EP1178825A2 Adjuvant combination formulations
02/13/2002EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response
02/13/2002CN1335889A Chimeric gene encoding the antigenic determinants of four proteins of L.INFANTUM
02/13/2002CN1335888A OPG fusion protein compositions and methods
02/12/2002US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus
02/07/2002WO2002010405A2 A human disintegrin protein
02/07/2002WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
02/07/2002WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
02/07/2002WO2002010381A1 Novel protein inhibitor of apoptosis proteins
02/07/2002WO2002010219A1 Oligolysine transducing domain, oligolysine-cargo molecule complex and uses thereof
02/07/2002WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof
02/07/2002WO2002010196A2 Identification of a novel glutamine transporter
02/07/2002WO2001072769A3 Methods for purifying highly anionic proteins
02/07/2002WO2001060970A3 Zinc finger domains and methods of identifying same
02/07/2002WO2001055211A3 Fil-1 theta dnas and polypeptides
02/07/2002WO2001036448A3 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions
02/07/2002WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them
02/07/2002WO2001018050A9 T2r taste receptor family
02/07/2002WO2001001150A3 Diagnostic test for thrombotic or thromboembolic disease
02/07/2002WO2000068376A8 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
02/07/2002US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer
02/07/2002US20020015699 Process for binding an antigen to a molecule having a high binding affinity to said antigen
02/07/2002DE10035156A1 New protein complex containing complex protein from botulinum toxin, useful for oral delivery of therapeutic polypeptide or low molecular weight pharmaceutical
02/07/2002CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof
02/07/2002CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof
02/07/2002CA2417278A1 Identification of a novel glutamine transporter
02/07/2002CA2417271A1 Novel protein inhibitor of apoptosis proteins